‘Two double decker buses’ worth of illegal erectile dysfunction drugs seized by MHRA The Medicines and Healthcare products Regulatory Agency seized over 4.4 million doses of unlicensed erectile dysfunction medicines in 2025 alone.…
Nearly 400 ‘dormant’ medicines targeted to be revived by government, industry and NHS scheme Medicines UK said that the collaborative project would focus on 'dormant' medicines that represent a serious risk to supply resilience and could result in medicines shortages.…
Everything you need to know about GLP-1s for weight loss From semaglutide to tirzepatide, this article collates the latest information on pharmacological weight-loss treatments, including evidence and best practice for their use.…
Class 1 recall issued for quetiapine oral suspension A national patient safety alert said that pharmacy teams must immediately stop supplying affected products, as well as quarantine and return any remaining stock.…
Health news round-up: NICE approvals, surveillance data and GLP-1 warnings A weekly summary of important developments in pharmacy and health news that you may have missed.…
PJ view: Access to rare disease treatment should not be a rarity Policymakers and healthcare leaders must persevere with long overdue changes to improve access to treatments for rare diseases.…
Weight-loss drugs among £45m of illegally traded medicines seized in 2025 Medicines and Healthcare products Regulatory Agency figures show that more than 5,000 glucagon-like peptide-1 products were seized in 2025.…
Two-prescriber sign-off no longer required for isotretinoin The Medicines and Healthcare products Regulatory Agency said that scrapping the two-prescriber requirement will address delays in access to acne treatment for patients aged under 18 years old.…
Clinical trial applications increased by almost 10% in 2025, MHRA data show Between January and November 2025, the Medicines and Healthcare products Regulatory Agency reported a 16% increase in trials involving healthy volunteers compared with the previous year.…
Addiction warnings on opioid and z-drug packaging to be strengthened The Medicines and Healthcare products Regulatory Agency said that patient information leaflets for gabapentinoids, benzodiazepines and z-drugs will include clearer definitions of dependence and addiction.…
